Notice2022-27140
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Targeted Mechanism of Action Presentations in Prescription Drug Promotion
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 14, 2022
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA or Agency) is announcing that a collection of information entitled "Targeted Mechanism of Action Presentations in Prescription Drug Promotion" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (PRA).
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 239 (Wednesday, December 14, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 239 (Wednesday, December 14, 2022)]
[Notices]
[Page 76492]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-27140]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2021-N-1050]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Targeted Mechanism of Action
Presentations in Prescription Drug Promotion
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
that a collection of information entitled ``Targeted Mechanism of
Action Presentations in Prescription Drug Promotion'' has been approved
by the Office of Management and Budget (OMB) under the Paperwork
Reduction Act of 1995 (PRA).
FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794,
P<a href="/cdn-cgi/l/email-protection#7d2f3c2e091c1b1b3d1b191c5315150e531a120b"><span class="__cf_email__" data-cfemail="ecbeadbf988d8a8aac8a888dc284849fc28b839a">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: On October 14, 2022, the Agency submitted a
proposed collection of information entitled ``Targeted Mechanism of
Action Presentations in Prescription Drug Promotion'' to OMB for review
and clearance under 44 U.S.C. 3507. An Agency may not conduct or
sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB control number.
OMB has now approved the information collection and has assigned OMB
control number 0910-0908. The approval expires on November 30, 2025. A
copy of the supporting statement for this information collection is
available on the internet at <a href="https://www.reginfo.gov/public/do/PRAMain">https://www.reginfo.gov/public/do/PRAMain</a>.
Dated: December 9, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-27140 Filed 12-13-22; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 14, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.